Inducible degradation of checkpoint kinase 2 links to cisplatin-induced resistance in ovarian cancer cells
- 1 March 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 328 (2) , 567-572
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancerGynecologic Oncology, 2004
- Chk2 activates E2F-1 in response to DNA damageNature Cell Biology, 2003
- Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 ProteinJournal of Biological Chemistry, 2003
- Chk2 Is a Tumor Suppressor That Regulates Apoptosis in both an Ataxia Telangiectasia Mutated (ATM)-Dependent and an ATM-Independent MannerMolecular and Cellular Biology, 2002
- The anaphase-promoting complex: it's not just for mitosis any moreGenes & Development, 2002
- Chk2 kinase — a busy messengerNature Reviews Molecular Cell Biology, 2001
- ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1Molecular and Cellular Biology, 2001
- DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2Science, 2000
- hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage responseNature, 2000
- Cyclin is degraded by the ubiquitin pathwayNature, 1991